Published in Acta Oncol on January 01, 2009
The targets of curcumin. Curr Drug Targets (2011) 1.76
Role of apoptosis in disease. Aging (Albany NY) (2012) 1.58
Mechanisms of apoptosis by the tumor suppressor Par-4. J Cell Physiol (2012) 1.13
Oral cancer overexpressed 1 (ORAOV1) regulates cell cycle and apoptosis in cervical cancer HeLa cells. Mol Cancer (2010) 0.99
Antitumor peptides from marine organisms. Mar Drugs (2011) 0.99
Aspirin induces apoptosis in vitro and inhibits tumor growth of human hepatocellular carcinoma cells in a nude mouse xenograft model. Int J Oncol (2011) 0.97
Momordica charantia Extract Induces Apoptosis in Human Cancer Cells through Caspase- and Mitochondria-Dependent Pathways. Evid Based Complement Alternat Med (2012) 0.95
Upregulation of microRNA135a-3p and death receptor 5 plays a critical role in Tanshinone I sensitized prostate cancer cells to TRAIL induced apoptosis. Oncotarget (2014) 0.93
Simultaneous siRNA-mediated knockdown of antiapoptotic BCL2, Bcl-xL, XIAP and survivin in bladder cancer cells. Int J Oncol (2012) 0.90
Induction of apoptosis by laminarin, regulating the insulin-like growth factor-IR signaling pathways in HT-29 human colon cells. Int J Mol Med (2012) 0.87
Pomegranate Bioactive Constituents Suppress Cell Proliferation and Induce Apoptosis in an Experimental Model of Hepatocellular Carcinoma: Role of Wnt/ β -Catenin Signaling Pathway. Evid Based Complement Alternat Med (2013) 0.87
Hepatic arterial administration of ginsenoside Rg3 and transcatheter arterial embolization for the treatment of VX2 liver carcinomas. Exp Ther Med (2012) 0.80
Combined treatment with quercetin and imperatorin as a potent strategy for killing HeLa and Hep-2 cells. Mol Cell Biochem (2014) 0.80
Activations of Both Extrinsic and Intrinsic Pathways in HCT 116 Human Colorectal Cancer Cells Contribute to Apoptosis through p53-Mediated ATM/Fas Signaling by Emilia sonchifolia Extract, a Folklore Medicinal Plant. Evid Based Complement Alternat Med (2012) 0.79
Apoptosis deregulation in myeloproliferative neoplasms. Einstein (Sao Paulo) (2013) 0.79
Docosahexaenoic acid (DHA) sensitizes brain tumor cells to etoposide-induced apoptosis. Curr Mol Med (2011) 0.79
Boolean network-based model of the Bcl-2 family mediated MOMP regulation. Theor Biol Med Model (2013) 0.79
Inhibition of Apoptosis and Efficacy of Pan Caspase Inhibitor, Q-VD-OPh, in Models of Human Disease. J Cell Death (2015) 0.79
Bruceine D induces apoptosis in human chronic myeloid leukemia K562 cells via mitochondrial pathway. Am J Cancer Res (2016) 0.78
Induction of apoptosis by a peptide from Porphyra yezoensis: regulation of the insulin-like growth factor I receptor signaling pathway in MCF-7 cells. Int J Oncol (2014) 0.78
Hyperoxia accelerates Fas-mediated signaling and apoptosis in the lungs of Legionella pneumophila pneumonia. BMC Res Notes (2011) 0.78
Inhibition of Mcl-1 expression by citrate enhances the effect of Bcl-xL inhibitors on human ovarian carcinoma cells. J Ovarian Res (2013) 0.78
Experimental results using 3-bromopyruvate in mesothelioma: in vitro and in vivo studies. J Bioenerg Biomembr (2012) 0.77
Selective TRAIL-triggered apoptosis due to overexpression of TRAIL death receptor 5 (DR5) in P-glycoprotein-bearing multidrug resistant CEM/VBL1000 human leukemia cells. Int J Biochem Mol Biol (2010) 0.77
The role of sera from equine grass sickness on apoptosis induction in PC12 Tet-off p53 cell line. Vet Res Forum (2015) 0.75
Blockage of both the extrinsic and intrinsic pathways of diazinon-induced apoptosis in PaTu cells by magnesium oxide and selenium nanoparticles. Int J Nanomedicine (2016) 0.75
MicroRNA-148b Acts as a Tumor Suppressor in Cervical Cancer by Inducing G1/S-Phase Cell Cycle Arrest and Apoptosis in a Caspase-3-Dependent Manner. Med Sci Monit (2016) 0.75
Knockdown of WISP1 inhibit proliferation and induce apoptosis in ALL Jurkat cells. Int J Clin Exp Pathol (2015) 0.75
Apoptotic pathways as a therapeutic target for colorectal cancer treatment. World J Gastrointest Oncol (2016) 0.75
Sequential cytotoxicity: a theory examined using a series of 3,5-bis(benzylidene)-1-diethylphosphono-4-oxopiperidines and related phosphonic acids. Bioorg Med Chem Lett (2010) 0.75
Helicobacter pylori Eradication Downregulates Cellular Inhibitor of Apoptosis Protein 2 in Gastric Carcinogenesis. Gut Liver (2017) 0.75
The mathematical model of the Bcl-2 family mediated MOMP regulation can perform a non-trivial pattern recognition. PLoS One (2013) 0.75
Novel derivative of aminobenzenesulfonamide (3c) induces apoptosis in colorectal cancer cells through ROS generation and inhibits cell migration. BMC Cancer (2017) 0.75
Knockdown of inhibitor of growth protein 2 inhibits cell invasion and enhances chemosensitivity to 5-FU in human gastric cancer cells. Dig Dis Sci (2013) 0.75
Anti-Cancer Activity of Maize Bioactive Peptides. Front Chem (2017) 0.75
Gene expression profiling of primary cutaneous melanoma and clinical outcome. J Natl Cancer Inst (2006) 3.17
CCAT2, a novel noncoding RNA mapping to 8q24, underlies metastatic progression and chromosomal instability in colon cancer. Genome Res (2013) 2.57
Isolation and characterization of hepatic cancer cells with stem-like properties from hepatocellular carcinoma. J Gastrointestin Liver Dis (2010) 1.70
CCAT2, a novel long non-coding RNA in breast cancer: expression study and clinical correlations. Oncotarget (2013) 1.48
Gold nanoparticles conjugated with cisplatin/doxorubicin/capecitabine lower the chemoresistance of hepatocellular carcinoma-derived cancer cells. J Gastrointestin Liver Dis (2012) 1.00
Epigallocatechin-3-Gallate (EGCG) inhibits cell proliferation and migratory behaviour of triple negative breast cancer cells. J Nanosci Nanotechnol (2013) 0.88
MicroRNAs and cancer therapy - from bystanders to major players. Curr Med Chem (2013) 0.87
p53siRNA therapy reduces cell proliferation, migration and induces apoptosis in triple negative breast cancer cells. Mol Cell Biochem (2013) 0.87
Management of renal extraskeletal mesenchymal chondrosarcoma. BMC Surg (2014) 0.87
Another review on triple negative breast cancer. Are we on the right way towards the exit from the labyrinth? Breast (2013) 0.87
Metformin plus sorafenib highly impacts temozolomide resistant glioblastoma stem-like cells. J BUON (2014) 0.85
Non-coding RNAs as theranostics in human cancers. J Cell Biochem (2012) 0.85
Superior cytotoxicity and DNA cross-link induction by oxaliplatin versus cisplatin at lower cellular uptake in colorectal cancer cell lines. Anticancer Drugs (2012) 0.84
Soluble CD163 serum levels are elevated and correlated with IL-12 and CXCL10 in patients with long-standing rheumatoid arthritis. Rheumatol Int (2012) 0.83
Gene expression profiling reveals activation of the FA/BRCA pathway in advanced squamous cervical cancer with intrinsic resistance and therapy failure. BMC Cancer (2014) 0.83
Papillary thyroid microcarcinoma and ectopic papillary thyroid carcinoma in mediastinum: a case report. Clin Nucl Med (2012) 0.83
Sorafenib for advanced-stage hepatocellular carcinoma. Eur J Gastroenterol Hepatol (2012) 0.82
The relationship between the structure and biological actions of green tea catechins. Food Chem (2013) 0.82
Highly aggressive pathology of non-functional parathyroid carcinoma. Orphanet J Rare Dis (2013) 0.82
The relationships between biological activities and structure of flavan-3-ols. Int J Mol Sci (2011) 0.82
Repositioning metformin in cancer: genetics, drug targets, and new ways of delivery. Tumour Biol (2014) 0.82
Quantitative mRNA expression of genes involved in angiogenesis, coagulation and inflammation in multiforme glioblastoma tumoral tissue versus peritumoral brain tissue: lack of correlation with clinical data. Eur Cytokine Netw (2012) 0.81
Thyroid cancer in children: a 20-year study at a Romanian oncology institute. Endocr J (2012) 0.81
TNF-α gene knockout in triple negative breast cancer cell line induces apoptosis. Int J Mol Sci (2012) 0.80
The prognostic value of FOXP3+ T regulatory cells in colorectal cancer. J BUON (2015) 0.80
Early transcriptional pattern of angiogenesis induced by EGCG treatment in cervical tumour cells. J Cell Mol Med (2012) 0.80
Combining the chemotherapeutic effects of epigallocatechin 3-gallate with siRNA-mediated p53 knock-down results in synergic pro-apoptotic effects. Int J Nanomedicine (2012) 0.79
Th1 and Th2 profiles in patients with pancreatic cancer compared with chronic pancreatitis. Pancreas (2009) 0.79
5-Fluorouracil potentiates the anti-cancer effect of oxaliplatin on Colo320 colorectal adenocarcinoma cells. J Gastrointestin Liver Dis (2013) 0.78
Oxaliplatin induces different cellular and molecular chemoresistance patterns in colorectal cancer cell lines of identical origins. BMC Genomics (2013) 0.78
Electrochemical immunosensors in breast and ovarian cancer. Clin Chim Acta (2013) 0.78
Can we change our microbiome to prevent colorectal cancer development? Acta Oncol (2015) 0.78
Epigenetically regulated microRNAs and their prospect in cancer diagnosis. Expert Rev Mol Diagn (2014) 0.77
PDGF beta targeting in cervical cancer cells suggest a fine-tuning of compensatory signalling pathways to sustain tumourigenic stimulation. J Cell Mol Med (2014) 0.77
The role of Staphylococcal enterotoxin A in achieving oral tolerance to myelin basic protein in adult mice. Immunol Invest (2013) 0.77
Investigation of thyroid carcinoma over 40 years, using the database of the Ion Chiricuta Institute of Oncology Cluj-Napoca. J BUON (2014) 0.77
Assessment of cytotoxicity, apoptosis and DNA damages in Colo320 colorectal cancer cells selected for oxaliplatin resistance. Cell Biochem Funct (2011) 0.77
Pharmacokinetics Evaluation of Carbon Nanotubes Using FTIR Analysis and Histological Analysis. J Nanosci Nanotechnol (2015) 0.77
Novel technologies for oral squamous carcinoma biomarkers in diagnostics and prognostics. Acta Odontol Scand (2015) 0.76
Novel cellular and molecular approaches to stratification and treatment of colorectal cancer. J Gastrointestin Liver Dis (2012) 0.76
[The fundamental mechanisms of metastatic spread and chemotherapy resistance in lung cancer]. Pneumologia (2011) 0.76
The role of CDCP1 (CUB domain-containing protein 1) and ADAM12 (a disintegrin and metalloproteinase 12) in ovarian cancer. J BUON (2015) 0.76
Is there a correlation between peripheral blood expression of angiogenic transcriptional factors/receptors and colorectal cancer? J BUON (2015) 0.76
Efficient siRNA delivery system using carboxilated single-wall carbon nanotubes in cancer treatment. J Biomed Nanotechnol (2012) 0.76
The role of microRNAs in the pathogenesis of HIV-related lymphomas. Crit Rev Clin Lab Sci (2015) 0.76
Early apoptosis signals induced by a low dose of epigallocatechin 3-gallate interfere with apoptotic and cell death pathways. J Nanosci Nanotechnol (2012) 0.76
Clinical and pharmacokinetics study of oxaliplatin in colon cancer patients. J Gastrointestin Liver Dis (2009) 0.76
MicroRNAs in liver malignancies. Basic science applied in surgery. J BUON (2015) 0.76
Inhibition of tumor necrosis factor alpha using RNA interference in oral squamous cell carcinoma. J BUON (2015) 0.76
MicroRNAs as biomarkers for graft-versus-host disease following allogeneic stem cell transplantation. Ann Hematol (2015) 0.75
Interplay between cancer cells, macrophages and natural killer cells may actually decide the outcome of therapy with sorafenib. Hepatology (2014) 0.75
Sorafenib for the treatment of solid malignancies: what about the cancer microenvironment? Int J Nanomedicine (2013) 0.75
Thyroid carcinoma and primary amenorrhea due to Mayer-Rokitansky-Küster-Hauser syndrome: a case report. J Med Case Rep (2012) 0.75
Minimally invasive enucleation with zero ischemia for malignancies. The Cluj Napoca experience. Am J Case Rep (2013) 0.75
Cancer stem-like cells: the dark knights of clinical hematology and oncology. J BUON (2014) 0.75
Molecular angiogenesis profile as a tool to discriminate chronic pancreatitis (CP) from pancreatic cancer (PC). Pancreas (2011) 0.75
Transthoracic ultrasonography for the immunocompromised patient. A pilot project that introduces transthoracic ultrasonography for the follow-up of hematological patients in Romania. Rom J Intern Med (2017) 0.75
Allele-Specific Reprogramming of Cancer Metabolism by the Long Non-coding RNA CCAT2. Mol Cell (2016) 0.75
Tumor infiltrating lymphocytes as a prognostic factor in malignant melanoma. Review of the literature. J BUON (2017) 0.75
Parasitaemia and haematological changes in malaria-infected refugees in South Africa. S Afr Med J (2016) 0.75
Laparoscopic rectal resection versus conventional open approach for rectal cancer - a 4-year experience of a single center. J BUON (2016) 0.75
The effect of anaesthetic management on neutrophil gelatinase associated lipocalin (NGAL) levels after robotic surgical oncology. J BUON (2015) 0.75
Identifying molecular features for prostate cancer with Gleason 7 based on microarray gene expression profiles. Rom J Morphol Embryol (2011) 0.75
HLA Genotyping using Next Generation Sequencing. Rom J Intern Med (2016) 0.75
Biomarkers for the early detection of relapses in metastatic colorectal cancers. J BUON (2017) 0.75
Expression of CDCP1 and ADAM12 in the ovarian cancer microenvironment. J BUON (2016) 0.75